Avantax Planning Partners’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-198
Closed -$16K 567
2018
Q3
$16K Buy
+198
New +$12.9K ﹤0.01% 751
2018
Q2
Sell
-340
Closed -$14K 611
2018
Q1
$14K Buy
+340
New +$16.6K ﹤0.01% 910

Other funds holding EXAS

Avantax Planning Partners's EXAS Position: Q4 2018 in Review

Avantax Planning Partners sold out of Exact Sciences (EXAS) in Q4 2018, closing a stake of 198 shares — an estimated $16K sold.

Avantax Planning Partners first reported a position in EXAS in Q1 2018 and held it in 2 quarters. The position peaked at $16K in Q3 2018. 370 funds tracked by Wall St. Rank hold EXAS as of Q4 2018.

  • Avantax Planning Partners reported no remaining Exact Sciences position as of Q4 2018 after selling out during the quarter.
  • Avantax Planning Partners sold 198 Exact Sciences shares in Q4 2018, an estimated $16K.
  • Avantax Planning Partners first reported a position in Exact Sciences in Q1 2018 and held it in 2 quarters.
  • Avantax Planning Partners's Exact Sciences position peaked at $16K in Q3 2018.
  • 370 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2018.

Based on Avantax Planning Partners's 13F filing for Q4 2018, filed 14 Feb 2019.